Amgen cuts cholesterol drug price by 60 percent

You are here: Home > Latest news > Current Article

Amgen cuts cholesterol drug price by 60 percent

By Staff Report / Wednesday, October 24th, 2018 / Comments Off on Amgen cuts cholesterol drug price by 60 percent

Thousand Oaks biotech giant Amgen announced Oct. 24 that it had slashed the price of its cholesterol medication Repatha from $14,000 to $5,850, a reduction of nearly 60 percent. The move follows similar reductions and rebate programs by Sanofi and Regeneron for its product Praluent, which was selected as the preferred PCSK9 inhibitor therapy by…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.